The market growth of respiratory drug delivery can be attributed to factors such as the growing geriatric population globally and the rising number of patients suffering from respiratory diseases. According to the Office of Disease Prevention and Health Promotion, more than 25 million in the U.S. are suffering from asthma and 14.8 million adults have been diagnosed with COPD. Also, according to the WHO, smoking is considered to be a primary cause for COPD and more than 1 billion people inhale outdoor polluted air exposed to tobacco. These factors are leading to an upsurge in market growth.
The Respiratory Drug Delivery Market is segmented on the basis of product Formulation, Applications, Device Type, and region.
Major Formulation of Respiratory Drug Delivery Market covered are:
- Suspension Aerosols
- Solution Aerosols
- Dry Powder Formulations
Major Device Types of Respiratory Drug Delivery Market covered are:
- Metered Dose Inhalers (MDIs)
- Dry Powder Inhalers (DPIs)
- Nebulizers
Major Applications ofRespiratory Drug Delivery Market covered are:
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Cystic Fibrosis
Other factors, such as a rise in governmental & non-governmental initiatives is expected to provide the market with lucrative growth opportunities. Moreover, technological advancements for the development of innovative products by the key players are also boosting market growth. However, the high price of these devices and wastage of drug formulations during the use of such devices may curb market growth to a certain extent.
No comments:
Post a Comment